[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@investseekers It also hits obesity focused biotechs. $ZEAL and $GUBRA down with 4-6% This is an overreaction"
X Link @ResearchPulse1 2025-10-17T08:21Z 1493 followers, XXX engagements
"Obesity marketing has forever changed what is possible within marketing for pharmaceuticals. How patients has been converted to consumers. Here is a UK online comparison of the cost for each kg you lose depending what glp1 you choose. $LLY $NVO $VKTX $GUBRA $ZEAL"
X Link @ResearchPulse1 2025-10-16T14:48Z 1493 followers, 3991 engagements
"$LLY Mounjaro of to a great start in Korea. Its only few weeks ago (week 34) since Mounjaro was launched in Korea. They did it by undercutting the price of Wegovy with XX% which prompted $NVO to lower its prices with up to 42%. Mounjaro has almost caught Wegovy sales. Sep sales for Mounjaro was 70000 vs 85000 for Wegovy. $VKTX $GUBRA $ZEAL"
X Link @ResearchPulse1 2025-10-14T20:23Z 1493 followers, 2533 engagements
"$NVO launching Wegovy in Argentina Seems like they have more focus at teenagers in the launch. Sad to read XX% of teenagers in Argentina are obese. Wegovy is approved down to XX years. (Normal from XX years) and they have ongoing trials down to X years. $LLY $VKTX $GUBRA $ZEAL"
X Link @ResearchPulse1 2025-10-14T18:11Z 1492 followers, 1980 engagements